![Philina Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philina Lee
Director/Board Member at
DBV TECHNOLOGIES
Profile
Philina Lee is Chief Executive Officer at AdvanCell Isotopes Pty Ltd. since 2026 and Independent Director at DBV Technologies SA since 2025.
Former roles include Independent Director at Fusion Pharmaceuticals, Inc. from 2021 to 2024, Head-US Marketing at Algeta ASA, and SVP & Head-Portfolio Strategy at Blueprint Medicines Corp.
from 2021 to 2022.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of Alberta.
Philina Lee active positions
| Companies | Position | Start |
|---|---|---|
| DBV TECHNOLOGIES | Director/Board Member | 2025-10-29 |
AdvanCell Isotopes Pty Ltd.
 AdvanCell Isotopes Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a radiopharmaceutical firm | Chief Executive Officer | 2025-12-31 |
Former positions of Philina Lee
| Companies | Position | End |
|---|---|---|
| FUSN PHAR | Director/Board Member | 2024-06-03 |
| ALGETA ASA | Corporate Officer/Principal | - |
| BLUEPRINT MEDICINES CORPORATION | Corporate Officer/Principal | - |
Training of Philina Lee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
AdvanCell Isotopes Pty Ltd.
AdvanCell Isotopes Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a radiopharmaceutical firm | Commercial Services |
- Stock Market
- Insiders
- Philina Lee
